ASMC – IPSMC - Skin And Venereal Diseases
- Address
- lock Available on a paid plan
Skin and Connective Tissue Diseases
At ASMC – IPSMC - Skin And Venereal Diseases in Sofia, clinical research in dermatology focuses on improving care for inflammatory and chronic skin conditions. The main studies center on hidradenitis suppurativa, with additional work in atopic dermatitis and alopecia areata, aiming to evaluate new treatment options and better control of symptoms.
- Research on hidradenitis suppurativa to assess the safety and effectiveness of emerging therapies
- Trials in atopic dermatitis exploring treatment response and symptom improvement
- Studies in alopecia areata focused on helping restore hair growth and reduce disease burden
The site’s dermatology program is designed to test new therapies and improve long-term management for patients with difficult-to-treat skin disease.
Immune System Diseases
Clinical trials at this hospital/clinic also address immune-mediated disease, especially conditions where inflammation plays a major role. The research includes studies in hidradenitis suppurativa and atopic dermatitis, with the goal of finding treatments that can better reduce flare-ups and improve quality of life.
- Evaluation of therapies for hidradenitis suppurativa in patients with moderate to severe disease
- Investigation of treatment options for atopic dermatitis to improve disease control
- Assessment of how well new immune-targeted therapies relieve symptoms and maintain response
This work helps build a clearer picture of how to treat chronic inflammatory skin conditions more effectively.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
The site contributes to research on rare inherited skin disorders, including Netherton syndrome. These trials are aimed at understanding how new treatments may help patients with complex, lifelong disease and at improving clinical care for uncommon genetic conditions.
- Studies in Netherton syndrome examining whether new therapies can ease symptoms
- Research on rare genetic skin disease to support better treatment choices
- Work focused on improving symptom control and daily functioning in patients with inherited disorders
By including rare disease research, ASMC – IPSMC - Skin And Venereal Diseases supports efforts to expand treatment options for patients with limited choices.
Bacterial Infections and Mycoses
Some trials at this site are linked to infectious and inflammatory skin disease, reflecting the overlap between chronic skin damage and infection-related complications. Research in this area supports the evaluation of therapies that may help reduce disease activity and improve skin health.
- Clinical research relevant to skin infections and related inflammatory conditions
- Studies aimed at improving treatment outcomes in patients with persistent skin disease
- Assessment of new therapies that may help manage symptoms and complications more effectively
This therapeutic area complements the broader dermatology program by addressing conditions where infection and inflammation can occur together.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 therapeutic areas and 15 of 25 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 8 by active trials.
- 1Novartis Pharma AG2active
lock +7 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Incyte Corp.6trials
lock +9 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in ASMC – IPSMC - Skin And Venereal Diseases
lock Showing 1 of 31 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Multicenter, Double-Blind, Randomized Withdrawal Study of Subcutaneous Secukinumab for Long-Term Efficacy and Safety in Moderate to Severe Hidradenitis Suppurativa | Novartis Pharma AG | Phase III | Not Recruiting | Mar 2020 | Jun 2026 |
IMP list
lock Showing 1 of 25 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Upadacitinib | 4 | Unknown | 2019-01-02 | 2024-04-05 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.